Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 22 Neoplasms 16 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 8 Neoplasm Metastasis 7 Lung Neoplasms 7 Lymphoma 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Multiple Myeloma 5 Glioblastoma 5 Stomach Neoplasms 4 Leukemia 4 Fatigue 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Pain 3 Myelodysplastic Syndromes 3 Motor Activity 3 Melanoma 3 Fallopian Tube Neoplasms 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2

Interventions

lutetium Lu 177 dotatate 34 Everolimus 33 lanreotide 13 gallium Ga 68 dotatate 13 Temozolomide 13 Magnetic Resonance Spectroscopy 13 Nivolumab 12 pembrolizumab 11 Octreotide 11 Capecitabine 11 177Lu-octreotide, DOTA(0)-Tyr(3)- 10 cabozantinib 9 Positron Emission Tomography Computed Tomography 9 3-Iodobenzylguanidine 9 surufatinib 8 Sunitinib 8 Specimen Handling 7 Carboplatin 7 pasireotide 6 amino-acid, glucose, and electrolyte solution 6 90Y-octreotide, DOTA-Tyr(3)- 6 lenvatinib 5 Lutetium-177 5 Ipilimumab 5 Fluorodeoxyglucose F18 5 Etoposide 5 Cisplatin 5 Bevacizumab 5 telotristat ethyl 4 olaparib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroendocrine Tumors × Palliative Care × Clear all

NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡